HRP20120277T1 - Sastav oktenidina - Google Patents
Sastav oktenidina Download PDFInfo
- Publication number
- HRP20120277T1 HRP20120277T1 HRP20120277AT HRP20120277T HRP20120277T1 HR P20120277 T1 HRP20120277 T1 HR P20120277T1 HR P20120277A T HRP20120277A T HR P20120277AT HR P20120277 T HRP20120277 T HR P20120277T HR P20120277 T1 HRP20120277 T1 HR P20120277T1
- Authority
- HR
- Croatia
- Prior art keywords
- octenidine
- polyalcohol
- solution
- composition according
- optionally
- Prior art date
Links
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 title claims abstract 40
- 229960001774 octenidine Drugs 0.000 title claims abstract 32
- 239000000203 mixture Substances 0.000 title claims abstract 12
- 150000005846 sugar alcohols Polymers 0.000 claims abstract 18
- 150000003839 salts Chemical class 0.000 claims abstract 10
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract 9
- 150000001241 acetals Chemical class 0.000 claims abstract 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 6
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract 5
- 229920000728 polyester Polymers 0.000 claims abstract 5
- 229920000570 polyether Polymers 0.000 claims abstract 5
- 229920000642 polymer Polymers 0.000 claims abstract 5
- 229910014033 C-OH Inorganic materials 0.000 claims abstract 4
- 229910014570 C—OH Inorganic materials 0.000 claims abstract 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract 4
- 125000003172 aldehyde group Chemical group 0.000 claims abstract 4
- 239000008103 glucose Substances 0.000 claims abstract 4
- 230000001225 therapeutic effect Effects 0.000 claims abstract 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract 3
- 125000002843 carboxylic acid group Chemical group 0.000 claims abstract 3
- -1 cyclic acetal Chemical class 0.000 claims abstract 3
- 125000004122 cyclic group Chemical group 0.000 claims abstract 3
- 125000000468 ketone group Chemical group 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims 9
- 238000011477 surgical intervention Methods 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 2
- 150000002016 disaccharides Chemical class 0.000 claims 2
- 150000002772 monosaccharides Chemical class 0.000 claims 2
- 210000004877 mucosa Anatomy 0.000 claims 2
- 210000004303 peritoneum Anatomy 0.000 claims 2
- 210000001215 vagina Anatomy 0.000 claims 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N 2,3,4,5,6-pentahydroxyhexanal Chemical compound OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 claims 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- 208000007976 Ketosis Diseases 0.000 claims 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 150000001320 aldopentoses Chemical class 0.000 claims 1
- 150000001323 aldoses Chemical class 0.000 claims 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940097043 glucuronic acid Drugs 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 150000002430 hydrocarbons Chemical class 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 150000002581 ketopentoses Chemical class 0.000 claims 1
- 150000002584 ketoses Chemical class 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 210000001835 viscera Anatomy 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08450183A EP2201951A1 (de) | 2008-11-14 | 2008-11-14 | Octenidin-Zusammensetzung |
PCT/EP2009/065111 WO2010055122A1 (de) | 2008-11-14 | 2009-11-13 | Octenidin-zusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20120277T1 true HRP20120277T1 (hr) | 2012-05-31 |
Family
ID=40383579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20120277AT HRP20120277T1 (hr) | 2008-11-14 | 2012-03-28 | Sastav oktenidina |
Country Status (30)
Country | Link |
---|---|
US (2) | US8940324B2 (pl) |
EP (2) | EP2201951A1 (pl) |
JP (1) | JP5756018B2 (pl) |
KR (1) | KR20110086718A (pl) |
CN (1) | CN102209542A (pl) |
AT (1) | ATE538788T1 (pl) |
AU (1) | AU2009315654B2 (pl) |
BR (1) | BRPI0915269A2 (pl) |
CA (1) | CA2742921A1 (pl) |
CO (1) | CO6331426A2 (pl) |
CU (1) | CU20110105A7 (pl) |
CY (1) | CY1112730T1 (pl) |
DK (1) | DK2291185T3 (pl) |
EA (1) | EA028177B1 (pl) |
ES (1) | ES2381815T3 (pl) |
GE (1) | GEP20135788B (pl) |
HK (1) | HK1156838A1 (pl) |
HR (1) | HRP20120277T1 (pl) |
IL (1) | IL212596A (pl) |
MX (1) | MX2011005092A (pl) |
NZ (1) | NZ592775A (pl) |
PE (1) | PE20110934A1 (pl) |
PL (1) | PL2291185T3 (pl) |
PT (1) | PT2291185E (pl) |
RS (1) | RS52299B (pl) |
SI (1) | SI2291185T1 (pl) |
SM (1) | SMT201200028B (pl) |
UA (1) | UA108190C2 (pl) |
WO (1) | WO2010055122A1 (pl) |
ZA (1) | ZA201103126B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009049504A1 (de) * | 2009-10-15 | 2011-04-21 | Schülke & Mayr GmbH | Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen |
DE102010025932A1 (de) | 2010-07-02 | 2012-01-05 | Schülke & Mayr GmbH | Antiseptikum auf der Basis von Bispyridiniumalkanen |
DE102010049113A1 (de) * | 2010-10-22 | 2012-04-26 | Schülke & Mayr GmbH | Mit einer antimikrobiellen Wirkstoffzubereitung getränktes textiles Flächengebilde mit einem Trägermaterial auf Basis von Polyolefin |
DE102012007212A1 (de) | 2012-04-11 | 2013-10-17 | Merz Pharma Gmbh & Co. Kgaa | Zubereitung zur topischen Anwendung auf Schleimhäuten mit Polyhexanid als Wirkstoff |
KR101718306B1 (ko) | 2015-07-27 | 2017-03-27 | 주식회사 퍼슨 | 옥테니딘염산염(Octenidine dihydrochloride)의 개선된 합성방법과 옥타니딘염산염을 포함하는 새로운 복합제의 제조방법 |
EA201890813A1 (ru) * | 2015-09-25 | 2018-09-28 | ФЛЕКСИГ ПАТЕНТ КОМПАНИ ЭлЭлСи | Новые композиции для защиты растений и их применение |
PL233480B1 (pl) * | 2017-09-28 | 2019-10-31 | Phytopharm Kleka Spolka Akcyjna | Koncentrat na bazie soli bis[4-(RHN)-1-pirydynio]alkanów w formie hydrożelu oraz sposób jego otrzymywania |
EP3771339A1 (en) * | 2019-07-29 | 2021-02-03 | The Procter & Gamble Company | Disinfectant composition |
CN113827565A (zh) * | 2020-06-16 | 2021-12-24 | 深圳长久康联生物科技有限公司 | 一种抗感染喷剂敷料及其制备方法、应用 |
CN113082029B (zh) * | 2021-03-02 | 2022-07-15 | 浙大宁波理工学院 | 一种伤口清洗消毒剂 |
CN117159784B (zh) * | 2023-03-31 | 2024-04-19 | 鹏拓生物科技(杭州)有限公司 | 用于难愈性创面修复的液体创可贴及其制备方法和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4420484A (en) | 1979-08-13 | 1983-12-13 | Sterling Drug Inc. | Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof |
DK505588D0 (da) * | 1988-02-26 | 1988-09-09 | Jesper Hamburger | Middel og anvendelse af samme |
DE3925540C1 (pl) | 1989-08-02 | 1990-08-30 | Schuelke & Mayr Gmbh, 2000 Norderstedt, De | |
CA2049728A1 (en) * | 1990-08-24 | 1992-02-25 | Kenji Kitamura | Washing composition capable of preventing and ameliorating skin irritation |
US5177065A (en) * | 1990-12-26 | 1993-01-05 | Silvetti Sr Anthony N | Monosaccharide containing wound healing preparation |
DE19647692C2 (de) * | 1996-11-05 | 2002-06-20 | Schuelke & Mayr Gmbh | Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion |
DE19647892A1 (de) | 1996-11-20 | 1998-06-04 | Forschungszentrum Juelich Gmbh | Verfahren zur katalytischen, enantioselektiven Reduktion von Ketonen |
AUPO690997A0 (en) * | 1997-05-20 | 1997-06-12 | Novapharm Research (Australia) Pty Ltd | Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism |
DE10109925B4 (de) | 2001-03-01 | 2004-11-25 | Antiseptica Chemisch-Pharmazeutische Produkte Gmbh | Wund- und Schleimhautantiseptikum |
DE10205883A1 (de) * | 2002-02-13 | 2003-08-21 | Schuelke & Mayr Gmbh | Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen |
DE10212321A1 (de) | 2002-03-20 | 2003-10-09 | Sanguibio Tech Ag | Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden |
US8198326B2 (en) * | 2004-09-07 | 2012-06-12 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
DE102004052308B4 (de) * | 2004-10-12 | 2013-04-04 | Divapharma-Knufinke Arzneimittelwerk Gmbh | Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums |
DE102005002645A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Alkoholische Zusammensetzungen für die Desinfektion |
DE102005002644A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
DE102005058978A1 (de) | 2005-08-26 | 2007-03-29 | Bode Chemie Gmbh & Co. Kg | Wund- und Schleimhautdesinfektionsmittel |
DE102005063375A1 (de) | 2005-09-15 | 2007-04-19 | Schülke & Mayr GmbH | Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen |
DE102005045145A1 (de) | 2005-09-15 | 2007-03-29 | Schülke & Mayr GmbH | Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen |
FR2907683A1 (fr) | 2006-10-27 | 2008-05-02 | De Potter Philippe Viseux | Composition medicale pour cicatrisation des plaies et pansements permettant son application |
US9555167B2 (en) | 2006-12-11 | 2017-01-31 | 3M Innovative Properties Company | Biocompatible antimicrobial compositions |
US20080175801A1 (en) * | 2007-01-18 | 2008-07-24 | The Procter & Gamble Company | Stable peroxide containing personal care compositions |
-
2008
- 2008-11-14 EP EP08450183A patent/EP2201951A1/de not_active Withdrawn
-
2009
- 2009-11-13 JP JP2011536025A patent/JP5756018B2/ja not_active Expired - Fee Related
- 2009-11-13 SI SI200930217T patent/SI2291185T1/sl unknown
- 2009-11-13 KR KR20117012507A patent/KR20110086718A/ko not_active Application Discontinuation
- 2009-11-13 UA UAA201107410A patent/UA108190C2/ru unknown
- 2009-11-13 US US13/128,266 patent/US8940324B2/en not_active Expired - Fee Related
- 2009-11-13 DK DK09756292T patent/DK2291185T3/da active
- 2009-11-13 RS RSP20120133 patent/RS52299B/en unknown
- 2009-11-13 PT PT09756292T patent/PT2291185E/pt unknown
- 2009-11-13 BR BRPI0915269A patent/BRPI0915269A2/pt not_active IP Right Cessation
- 2009-11-13 AU AU2009315654A patent/AU2009315654B2/en not_active Ceased
- 2009-11-13 CA CA2742921A patent/CA2742921A1/en not_active Abandoned
- 2009-11-13 GE GEAP2009012244 patent/GEP20135788B/en unknown
- 2009-11-13 CN CN2009801448968A patent/CN102209542A/zh active Pending
- 2009-11-13 MX MX2011005092A patent/MX2011005092A/es active IP Right Grant
- 2009-11-13 EP EP09756292A patent/EP2291185B1/de not_active Revoked
- 2009-11-13 NZ NZ59277509A patent/NZ592775A/en not_active IP Right Cessation
- 2009-11-13 PE PE2011001041A patent/PE20110934A1/es not_active Application Discontinuation
- 2009-11-13 EA EA201100762A patent/EA028177B1/ru not_active IP Right Cessation
- 2009-11-13 WO PCT/EP2009/065111 patent/WO2010055122A1/de active Application Filing
- 2009-11-13 PL PL09756292T patent/PL2291185T3/pl unknown
- 2009-11-13 ES ES09756292T patent/ES2381815T3/es active Active
- 2009-11-13 AT AT09756292T patent/ATE538788T1/de active
-
2011
- 2011-04-28 ZA ZA2011/03126A patent/ZA201103126B/en unknown
- 2011-05-01 IL IL212596A patent/IL212596A/en not_active IP Right Cessation
- 2011-05-13 CU CU20110105A patent/CU20110105A7/es unknown
- 2011-05-25 CO CO11064767A patent/CO6331426A2/es not_active Application Discontinuation
- 2011-07-25 HK HK11107685A patent/HK1156838A1/xx not_active IP Right Cessation
-
2012
- 2012-03-28 HR HRP20120277AT patent/HRP20120277T1/hr unknown
- 2012-03-28 CY CY20121100317T patent/CY1112730T1/el unknown
- 2012-06-11 SM SM201200028T patent/SMT201200028B/it unknown
-
2014
- 2014-10-30 US US14/528,869 patent/US20150126557A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20120277T1 (hr) | Sastav oktenidina | |
ES2262529T3 (es) | Acidos aldonicos de oligosacaridos y su uso topico. | |
JP5202763B2 (ja) | アルギネートオリゴマーと抗生物質とによるアシネトバクター感染の治療 | |
ES2958621T3 (es) | Composiciones para el tratamiento tópico de infecciones microbianas | |
CA2994702A1 (en) | Compositions with permeation enhancers for drug delivery | |
BR112019000849B1 (pt) | Composições líquidas de limpeza com sistema antibacteriano e método de fabricação das mesmas | |
EP3060265B1 (en) | Chitosan stenting paste | |
ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
BR0211282B1 (pt) | curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador | |
ES2860098T3 (es) | Composición para la aplicación nasal | |
RU2011152518A (ru) | Применение композиции для лечения мукозита | |
KR102407408B1 (ko) | 알긴산계 항균성 화합물을 사용하는 염증 및 질병을 억제하기 위한 조성물 및 방법 | |
JP2009541476A5 (pl) | ||
CA2932987C (en) | Combination of glycosaminoglycans and cyclodextrins | |
JP2007522077A (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
JP7534284B2 (ja) | 薬物送達のための相乗的な透過促進剤を伴う組成物 | |
JP5572110B2 (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
WO2013087665A2 (en) | Cosmetic composition for skin or hair care | |
US9744192B2 (en) | Methods of treating chronic rhinosinusitis | |
ITRM20130268A1 (it) | Formulazioni oftalmiche acquose a base di azitromicina. | |
WO2002036600A3 (en) | Derivatised carbohydrates and their use in solid delivery systems | |
JP2023536594A (ja) | Prasinococcales由来のサッカライドの使用 |